(19)
(11) EP 0 968 285 A1

(12)

(43) Date of publication:
05.01.2000 Bulletin 2000/01

(21) Application number: 98906592.5

(22) Date of filing: 19.02.1998
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/62, C12N 1/21, C07K 14/475, C07K 16/18, G01N 33/68, A61K 38/18
(86) International application number:
PCT/US9803/283
(87) International publication number:
WO 9837/195 (27.08.1998 Gazette 1998/34)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 19.02.1997 US 38279 P

(71) Applicants:
  • REGENERON PHARMACEUTICALS, INC.
    Tarrytown, NY 10591-6707 (US)
  • The Regents of the University of California
    Oakland,CA 94607-5200 (US)

(72) Inventors:
  • VALENZUELA, David, M.
    Franklin Square, NY 11010 (US)
  • ECONOMIDES, Aris
    New York, NY 10027 (US)
  • HARLAND, Richard, M.
    Moraga, CA 94556 (US)
  • HSU, David
    Albany, CA 04706 (US)
  • STAHL, Neil
    Carmel, NY 10512 (US)

(74) Representative: Goldin, Douglas Michael et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) MORPHOGENIC PROTEINS